← Browse by Condition
Medical Condition

dmmr solid malignant tumor

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05086692 Phase 1, Phase 2
Recruiting

A Beta-only IL-2 ImmunoTherapY Study

Enrollment
115 pts
Location
United States, Austr...
Sponsor
Medicenna Therapeutics, Inc.
View Trial →